State of Renal Denervation, The Paradise System and Clinical Developments at EuroPCR 2021

From proof to practice - Treating hypertension with ultrasound renal denervation - EuroPCR 2023Подробнее

How does Paradise renal denervation fit into hypertension treatment management? - EuroPCR 2021Подробнее

Ultrasound Renal Denervation with Dr. Sharp at EuroPCR 2021Подробнее

RADIANCE-HTN SOLO: primary outcomes of renal denervation - session webcastПодробнее

How does Ultrasound Renal Denervation fit into Hypertension treatment?Подробнее

RADIANCE-HTN TRIO: key takeaways and implications for the treatment of hypertension - EuroPCR 2021Подробнее

Redefining hypertension management with renal denervation - EuroPCR 2021Подробнее

Ultrasound Renal Denervation - Patient Perspective, Referral Development - Discussion @ EuroPCR 2021Подробнее

Hypertension management in 2022: Latest data on renal denervation from #EuroPCR 2022Подробнее

Renal Denervation for Hypertension: State of the Science in 2021Подробнее

Renal denervation for treatment of hypertension – heading for new shores - WebinarПодробнее

Redefining Hypertension Management with Renal DenervationПодробнее

Alcohol-mediated endovascular renal denervation The PEREGRINE studyПодробнее

Advancing the treatment of uncontrolled hypertension with ultrasound renal denervation - EuroPCR2022Подробнее

RADIANCE signals a bright future for renal denervation - EuroPCR 2018Подробнее

TCT 22: RADIANCE II Pivotal Trial: Paradise Renal Denervation System in Pts With HypertensionПодробнее

RADIANCE-HTN-TRIO: what does this mean for the treatment of hypertension? - EuroPCR 2021Подробнее

A review of the RADIANCE-HTN global clinical trial programme: a focus on the TRIO cohort - #EuroPCRПодробнее